Skip to main content
Equibles
RMD logo

RMD · Resmed Inc · Metrics

Track RMD — free

Use RMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$245.03 +5.26 (+2.19%)
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$34.59B
Shares
144.25M
Volume · Oct 20 136.79K Avg daily vol (3M) 1.3M

RMD metrics

113 of 116 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$239.77
Market cap
$34.59B

Price action

20 metrics
Price change (1W)
+2.2%
Price change (30D)
+7.2%
Price change (3M)
+20.7%
Price change (6M)
+6.0%
Price change (YTD)
-0.5%
Price change (1Y)
-10.6%
Trailing year
Price change (5Y)
-7.8%
52-week high
$275.96
52-week low
$182.82
Change from 52-week high
-13.1%
Change from 52-week low
+31.2%
Annualized volatility
28.7%
Annualized volatility (3M)
29.1%
Beta
0.4
RSI (14D)
67.3
Price vs SMA 50
+5.4%
Price vs SMA 200
+6.6%
Avg volume (3M)
1.30M
Relative volume
0.7
Average dollar volume
$291.38M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
144.25M

Valuation

12 metrics
P / E (TTM)
23.0
Trailing earnings · reciprocal yield 4.4%
PEG ratio
9.9
EV / revenue
6.0×
reciprocal yield 16.8%
EV / EBITDA
16.1×
reciprocal yield 6.2%
EV / EBIT
17.8×
reciprocal yield 5.6%
P / sales
6.1×
reciprocal yield 16.4%
P / book
5.2
reciprocal yield 19.1%
FCF yield
4.8%
TTM · current market cap
Buyback yield
2.0%
P / FCF
20.9
reciprocal yield 4.8%
P / operating cash flow
19.1
reciprocal yield 5.2%
Earnings yield
4.4%

Historical valuation

8 metrics
P / E historical average (3Y)
27.3×
reciprocal yield 3.7%
P / E historical average (5Y)
37.5×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
6.6×
reciprocal yield 15.1%
EV / revenue historical average (5Y)
7.3×
reciprocal yield 13.8%
EV / EBIT historical average (3Y)
21.8×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
25.0×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
19.4×
reciprocal yield 5.2%
EV / EBITDA historical average (5Y)
21.9×
reciprocal yield 4.6%

Dividends & buybacks

7 metrics
Dividend yield
1.0%
Trailing 12 months
Payout ratio
23.0%
Shareholder yield
3.0%
Dividend / share (TTM)
$2.46
Dividend growth YoY
+12.3%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-20

Earnings calendar

2 metrics
Next earnings
2026-10-29
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
61.1%
Operating margin
33.4%
Trailing 12 months
Net margin
26.9%
Gross profit (TTM)
$3.45B
Operating profit (TTM)
$1.89B
Net income (TTM)
$1.52B
Trailing 12 months
Diluted EPS (TTM)
$10.43
FCF margin
29.2%
Effective tax rate
20.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$38.71
Gross profit per diluted share (TTM)
$23.64
Operating profit per diluted share (TTM)
$12.92
EBITDA per diluted share (TTM)
$14.30
Net income per diluted share (TTM)
$10.43
Operating cash flow per diluted share (TTM)
$12.37
Free cash flow per diluted share (TTM)
$11.30
Capital expenditures per diluted share (TTM)
$1.07
R&D per diluted share (TTM)
$2.59
Stock compensation per diluted share (TTM)
$0.71
Book value per share
$45.66

Growth

11 metrics
Revenue growth YoY
+8.6%
Year over year
Net income growth YoY
+1.0%
Revenue (TTM)
$5.65B
Trailing 12 months
EPS growth YoY
+2.3%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.2%
Revenue CAGR (5Y)
+12.1%
EPS CAGR (3Y)
+19.6%
EPS CAGR (5Y)
+26.3%
FCF CAGR (3Y)
+42.2%
FCF CAGR (5Y)
+21.1%

Quality

14 metrics
Return on equity
23.1%
Return on assets
17.0%
Debt / equity
0.1
Current ratio
3.1
EBITDA (TTM)
$2.09B
Free cash flow (TTM)
$1.65B
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
-0.4
Return on invested capital
25.9%
Trailing 12 months
Net cash
$809.87M
Latest balance sheet
Cash & equivalents
$1.47B
Total assets
$8.97B
Total debt
$659.37M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.81B
Capital expenditures (TTM)
$156.28M
R&D (TTM)
$378.29M
SG&A (TTM)
$1.12B
Stock compensation (TTM)
$104.35M
R&D / revenue
6.7%
Stock compensation / revenue
1.8%

Ownership (13F)

3 metrics
13F filers
898
13F filer change QoQ
-54
Institutional ownership
69.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
25.2%

Short interest

3 metrics
Short interest
8.9%
Latest settlement · 9.9 days to cover
Days to cover
9.9d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.29M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 943819 CUSIP 761152107 13F (30d) 125 filings 120 filers Visit website Investor relations